Roche Obesity Drug Enicepatide Delivers 22.7% Weight Loss in Mid-Stage Trial, Challenges Wegovy, Zepbound
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok